4.8 Article

Impact of pre-adapted HIV transmission

Journal

NATURE MEDICINE
Volume 22, Issue 6, Pages 606-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm.4100

Keywords

-

Funding

  1. Merck
  2. NIH National Institute of Allergy and Infectious Diseases (NIAID)
  3. NIAID [R01 AI112566, R56 AI098551, R01 AI64060, R37 AI51231, P01 AI074415, U01 AI 66454, RO1 AI46995, R01 AI071906]
  4. Canadian Institutes of Health Research [MOP-93536, HOP-115700]
  5. Wellcome Trust [WT104748MA]
  6. NIH [U01 AI 068636]
  7. National Institute of Mental Health (NIMH)
  8. National Institute of Dental and Craniofacial Research (NIDCR)
  9. International AIDS Vaccine Initiative
  10. Virology Core at the Emory Center for AIDS Research [P30 AI050409]
  11. Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research [P30 AI027767]
  12. Tennessee Center for AIDS Research [P30 AI110527]
  13. Yerkes National Primate Research Center through NIH Office of the Director [P51OD11132]
  14. Action Cycling Fellowship
  15. South African Department of Science and Technology
  16. National Research Foundation through South Africa Research Chairs Initiative
  17. Howard Hughes Medical Institute
  18. Victor Daitz Foundation
  19. CIHR/GSK
  20. Michael Smith Foundation for Health Research
  21. Medical Research Council [MR/L006588/1] Funding Source: researchfish
  22. MRC [MR/L006588/1] Funding Source: UKRI

Ask authors/readers for more resources

Human leukocyte antigen class I (HLA)-restricted CD8(+) T lymphocyte (CTL) responses are crucial to HIV-1 control. Although HIV can evade these responses, the longer-term impact of viral escape mutants remains unclear, as these variants can also reduce intrinsic viral fitness. To address this, we here developed a metric to determine the degree of HIV adaptation to an HLA profile. We demonstrate that transmission of viruses that are pre-adapted to the HLA molecules expressed in the recipient is associated with impaired immunogenicity, elevated viral load and accelerated CD4(+) T cell decline. Furthermore, the extent of pre-adaptation among circulating viruses explains much of the variation in outcomes attributed to the expression of certain HLA alleles. Thus, viral pre-adaptation exploits 'holes' in the immune response. Accounting for these holes may be key for vaccine strategies seeking to elicit functional responses from viral variants, and to HIV cure strategies that require broad CTL responses to achieve successful eradication of HIV reservoirs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available